medigraphic.com
Colegio de Medicina Interna de México.

2022, Number 3

<< Back Next >>

Med Int Mex 2022; 38 (3)

Bitartrate or tartrate potassium for the treatment of dropsy in the New Kingdom of Granada

Tuta-Quintero E, Briceño-Balcázar I, Martínez-Lozano JC, Olaya-Galindo MD, Gómez-Gutiérrez A

Language: Spanish
References: 31
Page: 669-675
PDF size: 222.19 Kb.


ABSTRACT

Hydrops has been the object of study throughout history in search of understanding its etiology, pathophysiology and treatment. The objective of this study is to analyze the herbal medical prescription that circulated in the New Kingdom of Granada during the 18th and 19th centuries for the treatment of dropsy, understanding the cultural and scientific bases of this in the New Granada population, to evaluate the efficacy and current scope of the treatment compared to the standard management of hydrops. A documentary search in the Cipriano Rodríguez Santamaría Historical Archive of the Octavio Arizmendi Posada Library of the University of La Sabana, Colombia, was done. The document is called “Hydrops”. Simultaneously, a review of the current medical evidence was carried out in the bibliographic databases PubMed, Embase, LILACS, Science Direct and academic Google, without time limit and in English and Spanish. It is preserved a large number of medical recipes from the Neogranadian era, among which one stands out for the treatment of hydrops based on bitartrate or tartrate potassium as the main compound. At present the scientific basis is unknown that allows to determine its potential beneficial effect for the management of hydrops at that time. What is clear is that its exaggerated use is associated with potentially fatal hyperkalemia. The recipe being analyzed is not indicated for a specific disease to be treated, as it was used to control signs and symptoms such as edema and ascites, which can correspond to a wide spectrum of diseases.


REFERENCES

  1. Jácome Roca A. Historia de los medicamentos. Acad NacMedicina (Colombia). Ed. Kimpres, 2003; IV: 125-8, 2003.

  2. Herrera F. Visión retrospectiva de la farmacología de losdigitálicos. Rev Med Caracas 2000; 108: 157-68.

  3. Pico RP. Las boticas en el Nuevo Reino de Granada a finalesdel período colonial: El lento camino hacia la modernidad.Medicina (Bogotá) 2015; 37 (3): 223-41.

  4. Rivera Sandoval, Javier, De todo como en botica, pp. 13-15.

  5. Aronson J. When I use a word – dropsy, BMJ 2003; 326: 491.

  6. Talamonti G, D’Aliberti G, Cenzato M, Aulus CorneliusCelsus and the head injuries. World Neurosurg 2019. doi:https://doi.org/10.1016/j.wneu.2019.09.119.

  7. Jarcho S. Ascites as described by Aulus Cornelius Celsus (ca.A. D. 30). Am J Cardiol 1958; 2: 507-508. doi: 10.1016/0002-9149(58)90339-4.

  8. Riva MA, Cesana F, Achilli F, Scordo F, Cesana G. The “thirstydropsy”: Early descriptions in medical and non-medicalauthors of thirst as symptom of chronic heart failure. Int JCardiol 2017. doi: 10.1016/j.ijcard.2017.07.104.

  9. Andreae L, Fine LG. Unravelling dropsy: From MarcelloMalpighi’s discovery of the capillaries (1661) to StephenHales’ production of oedema in an experimental model(1733). Am J Nephrol 1997; 17 (3-4): 359-68. doi:

  10. 10.1159/000169123.10. Muratori LA. Antichità italiane. Dissertazioni. Disserta-zioneXXXIII. Catalogo di molte voci Italiane, delle quali si cercal’origine. Lettere S – Z. SECCHIA. En: http://www. classicitaliani.it/muratori/dissert33catalogo5.htm; consultado el23 de julio de 200.

  11. Timio M, Capodicasa E. Ippolito Albertini and MichaelAlbertus: Disparate old and innovative theories on dropsyand edema. Am J Nephrol 2002; 22 (2-3): 220-4. doi:10.1159/000063765.

  12. Landis EM. Micro-injection studies of capillary blood pressurein human skin. Heart 1930; 209. Capillary Pressure andCapillary Permeability. Physiol Reo 1934; 404.

  13. Eberle J. A treatise of the materia medica and therapeutics.6th ed. Grigg, Elliot & Co., Philadelphia, 1847.

  14. Lazzaroni M, Casini V, Bianchi-Porro G. Role or carbondioxide-releasing suppositories in the treatment of chronicfunctional constipation: a double-blind, randomised,placebo-controlled trial. Clin Drug Investig 2005; 25: 499-505. doi: 10.2165/00044011-200525080-00002.

  15. GrannyMed.com. Cream of tartar for bladder infection (cystitis).Available at http://www.grannymed.com/remedies/conditions/ bladder-infection/cream-of-tartar-for-bladderinfection-cystitis. Accessed 5 July 2012.

  16. Hull JS. No-smokin’ the cream of tartar. 2011. Availableat http://www.janethull.com/newsletter/0807/nosmokin_the_ cream_of_tartar.php. Accessed 5 July 2012.

  17. Tyson WT. On poisoning with cream of tartar. Lond MedGaz 1837; 517 (21): 177-178.

  18. Rusyniak DE, Durant PJ, Mowry JB, Johnson JA, SanftlebenJA, Smith JM. Life-threatening hyperkalemia from creamof tartar ingestion. J Med Toxicol 2012; 9 (1): 79-81.doi:10.1007/s13181-012-0255-x.

  19. Hunter RW, Bailey MA. Hyperkalemia: pathophysiology, riskfactors and consequences. Nephrol Dial Transplant 2019;34 (Suppl 3): iii2‐iii11. doi:10.1093/ndt/gfz206.

  20. Montford JR, Linas S. How dangerous is hyperkalemia? JAm Soc Nephrol 2017; 28 (11): 3155‐3165. doi:10.1681/ASN.2016121344.

  21. Ouyang JM, Deng SP, Zhou N, Tieke B. Effect of tartrateswith various counterions on the precipitation of calciumoxalate in vesicle solutions. Colloids Surfaces A PhysicochemEng Asp 2005; 256 (1 SPEC. ISS.): 21-7.

  22. Wang Shao-Chi, Yang Yun, Liu Jing, Jiang Ai-Dou, Chu Zhao-Xing, Chen Si-Ying, Gong Guo-Qing, He Guang-Wei, Xu Yun-Gen, Zhu Qi-Hua. Discovery of novel limonin derivatives aspotent anti-inflammatory and analgesic agents. Chin J NatMed 2018; 16 (3): 231-240.

  23. Runyu Yang, Changqin Song, Jiaxi Chen, Lvqi Zhou, XiuboJiang, Xiaomei Cao, Yang Sun, Qi Zhang. Limonin amelioratesacetaminophen-induced hepatotoxicity by activatingNrf2 antioxidative pathway and inhibiting NF-κB inflammatoryresponse via upregulating Sirt1. Phytomedicine 2020.doi: https://doi.org/10.1016/j.phymed.2020.153211.

  24. Zaa C, Valdivia M, Marcelo Á. Efecto antiinflamatorio yantioxidante del extracto hidroalcohólico de Petiveriaalliacea. Rev Peru Biol 2012; 19 (3): 329-34.

  25. Unger T, Borghi C, Charchar F, Khan NA, Poulter NR,Prabhakaran D, et al. 2020 International Society of HypertensionGlobal Hypertension Practice Guidelines.Hypertension 2020; 1334-57.

  26. Wang H, Cheng L, Lin D, Ma Z, Deng X. Lemon fruitslower the blood uric acid levels in humans and mice.Sci Hortic (Amsterdam). 2017; 220: 4-10. http://dx.doi.org/10.1016/j.scienta.2017.03.023.

  27. O’Brien JG, Chennubhotla SA, Chennubhotla RV. Treatmentof edema. Am Fam Physician 2005; 71 (11): 2111‐2117.

  28. Mullens W, Damman K, Harjola VP, Mebazaa A, et al. Theuse of diuretics in heart failure with congestion - a positionstatement from the Heart Failure Association of theEuropean Society of Cardiology. Eur J Heart Fail 2019. doi:10.1002/ejhf.1369.

  29. Clark AL, Cleland JG. Causes and treatment of oedema inpatients with heart failure. Nat Rev Cardiol 2013; 10 (3):156‐170. doi:10.1038/nrcardio.2012.191.

  30. Fuchs C, Ertmer C, Rehberg S. Effects of vasodilators onhaemodynamic coherence. Best Pract Res Clin Anaesthesiol2016; 30 (4): 479‐489. doi:10.1016/j.bpa.2016.10.003.

  31. Travessa AM, Menezes Falcão L. Vasodilators in acute heartfailure - evidence based on new studies. Eur J Intern Med2018; 51: 1‐10. doi:10.1016/j.ejim.2018.02.020.




2020     |     www.medigraphic.com